Clinical Trial Update: UGT1A1 Combined With Pharmacokinetics of SN-38 in CPT-11-based CRT in Patients With Advanced Rectal Cancer [NA]

View source ↗

Summary

Clinical trial update investigating the pharmacokinetics of SN-38 and UGT1A1 in CPT-11–based chemoradiation for locally advanced rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• CPT-11 (Irinotecan)

Snippet

Sponsor: Fudan University | Conditions: Locally Advanced Rectal Cancer | NA | Status: UNKNOWN